Mace Rothenberg, MD is President and Executive Director of the Museum of Medicine and Biomedical Discovery.  His nearly 40-year career has spanned government, academia, industry, and the not-for-profit sector.  Prior to his current role, Dr. Rothenberg was Chief Medical Officer of Pfizer (2019-2021) and Chief Development Officer/Head of Clinical Development for Pfizer Oncology (2008-end of 2018).  Prior to joining Pfizer, Dr. Rothenberg was Professor of Medicine at Vanderbilt University (1998-2008) and the University of Texas Health Science Center at San Antonio (1991-1998).  Dr. Rothenberg began his career as Special Assistant to the Director, Division of Cancer Treatment at the National Cancer Institute in Bethesda, Maryland (1988-1991).

Dr. Rothenberg received his BA magna cum laude from the University of Pennsylvania, his MD from New York University, his post-graduate training in Internal Medicine at Vanderbilt, and his medical oncology training at the National Cancer Institute.  He is a Fellow of the American College of Physicians and the American Society of Clinical Oncology.

In addition to his role on Chiara’s board, Mace is a director of Tango Therapeutics, Surrozen, and Aulos Biosciences.  He also serves on the board of several non-profit organizations.